GTBP

GT Biopharma (GTBP)

GT Biopharma Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GTBP

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
06/07/2024	2:15PM	iHub Newswire	FeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
06/07/2024	5:25PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
05/23/2024	8:31PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
05/23/2024	6:04AM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GTBP	GT Biopharma Inc
05/23/2024	6:02AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
05/15/2024	5:00PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
02/14/2024	2:46PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
02/01/2024	12:15PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
12/21/2023	3:30PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
12/04/2023	5:00PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
11/06/2023	5:25PM	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
11/06/2023	5:23PM	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
11/06/2023	5:21PM	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:GTBP	GT Biopharma Inc
11/01/2023	9:00AM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
10/27/2023	5:23PM	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:GTBP	GT Biopharma Inc
09/19/2023	11:56AM	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GTBP	GT Biopharma Inc
08/22/2023	4:55PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
08/15/2023	7:29PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
08/15/2023	7:26PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
08/07/2023	9:30AM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
07/05/2023	9:00AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
05/05/2023	5:30PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:GTBP	GT Biopharma Inc
05/05/2023	5:29PM	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:GTBP	GT Biopharma Inc
05/04/2023	7:15PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GTBP	GT Biopharma Inc
05/04/2023	9:06AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc
04/11/2023	7:00PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GTBP	GT Biopharma Inc
03/30/2023	5:02PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GTBP	GT Biopharma Inc
02/14/2023	12:55PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GTBP	GT Biopharma Inc
01/04/2023	6:23AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc
01/04/2023	6:02AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:GTBP	GT Biopharma Inc